InterVenn Biosciences utilizes a proprietary high-throughput glycoproteomic interrogation platform using artificial intelligence and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together with applications from the Vista suite of solutions for treatment and monitoring, immune profiling, patient stratification, and disease progression.

Biotechnology

InterVenn Biosciences

InterVenn Biosciences' headquarters in South San Francisco, CA, United States

Andrew Quong

Peter S.

Kaitlynn Moser

Ada Wong

Julio Taboada

Padmanee Sharma

James Allison

Regina Benjamin

Arnold Levine

Bartha Knoppers

Edith Mitchell

James Almas

Carolyn Bertozzi

Evelien Dekker

Heiko Pohl

John Nik Ding

Aasma Shaukat

Heinz Läubli

Samir Gupta

Carlito Lebrilla

Description

People (7)

Chad Pickering

Rachel Rice

Maurice Wong

Andrew Quong

Julio Taboada

Jaime P.

Rudy Peters

Jobs